Vanda Pharmaceuticals (VNDA) Assets (2016 - 2025)
Historic Assets for Vanda Pharmaceuticals (VNDA) over the last 17 years, with Q3 2025 value amounting to $601.1 million.
- Vanda Pharmaceuticals' Assets fell 681.66% to $601.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $601.1 million, marking a year-over-year decrease of 681.66%. This contributed to the annual value of $656.2 million for FY2024, which is 119.73% up from last year.
- Per Vanda Pharmaceuticals' latest filing, its Assets stood at $601.1 million for Q3 2025, which was down 681.66% from $624.7 million recorded in Q2 2025.
- Vanda Pharmaceuticals' Assets' 5-year high stood at $656.2 million during Q4 2024, with a 5-year trough of $543.2 million in Q1 2021.
- Over the past 5 years, Vanda Pharmaceuticals' median Assets value was $631.9 million (recorded in 2025), while the average stood at $620.7 million.
- As far as peak fluctuations go, Vanda Pharmaceuticals' Assets soared by 1237.86% in 2021, and later tumbled by 681.66% in 2025.
- Quarter analysis of 5 years shows Vanda Pharmaceuticals' Assets stood at $593.8 million in 2021, then increased by 6.81% to $634.2 million in 2022, then increased by 2.24% to $648.4 million in 2023, then increased by 1.2% to $656.2 million in 2024, then fell by 8.39% to $601.1 million in 2025.
- Its Assets was $601.1 million in Q3 2025, compared to $624.7 million in Q2 2025 and $631.9 million in Q1 2025.